801
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

Influenza vaccine effectiveness assessment through sentinel virological data in three post-pandemic seasons

, , , , , , , , , & show all
Pages 225-230 | Received 30 Jun 2014, Published online: 01 Nov 2014

References

  • HandaR, TeoS, BooyR. Influenza: current evidence and informed predictions. Expert Rev Vaccines2004; 3:443 - 51; http://dx.doi.org/10.1586/14760584.3.4.443; PMID: 15270649
  • Public Health Agency of Catalonia, Immunization Program. Technical guidelines for seasonal influenza immunization.[cited 2014 Mar 15] Available from. URL: http://www20.gencat.cat/portal/site/canalsalut
  • ValencianoM, KisslingE, CiancioBC, MorenA. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine2010; 28:7381 - 8; http://dx.doi.org/10.1016/j.vaccine.2010.09.010; PMID: 20851086
  • ShimE, GalvaniAP. Distinguishing vaccine efficacy and effectiveness. Vaccine2012; 30:6700 - 5; http://dx.doi.org/10.1016/j.vaccine.2012.08.045; PMID: 22944629
  • OrensteinWA, BernierRH, DonderoTJ, HinmanAR, MarksJS, BartKJ, SirotkinB. Field evaluation of vaccine efficacy. Bull World Health Organ1985; 63:1055 - 68; PMID: 3879673
  • HalloranME. Overview of vaccine field studies: types of effects and designs. J Biopharm Stat2006; 16:415 - 27; http://dx.doi.org/10.1080/10543400600719236; PMID: 16892904
  • KellyH, CarvilleK, GrantK, JacobyP, TranT, BarrI. Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS One2009; 4:e5079; http://dx.doi.org/10.1371/journal.pone.0005079; PMID: 19333374
  • Surveillance and Response to Emergencies in Public Health, Public Health Agencyu of Catalonia. Pla d'informació de les infeccions respiratòries agudes a Catalunya PIDIRAC.[cited 2014 Apr 1]; Available from. URL: http://www20.gencat.cat/portal/site/canalsalut
  • TornerN, BaricotM, MartínezA, ToledoD, GodoyP, DominguezÁ, Influenza Sentinel Surveillance Primary care physicians’ Network of Catalonia (PIDIRAC). Influenza sentinel surveillance network: a public health-primary care collaborative action to assess influenza A(H1N1)pmd09 in Catalonia, Spain. Hum Vaccin Immunother2013; 9:671 - 4; http://dx.doi.org/10.4161/hv.23264; PMID: 23396181
  • TornerN, MorteruelM, MartinezA, BasileL, IsantaR, PumarolaT. Differences in sentinel influenza confirmed incidence rates and clinical presentation of influenza virus: 2008-09 seasonal vs 2009-10 pandemic influenza. Hum Vaccin2011; 7:Suppl230 - 3; http://dx.doi.org/10.4161/hv.7.0.14612; PMID: 21285535
  • Centers for Disease Control and Prevention (CDC). Interim adjusted estimates of seasonal influenza vaccine effectiveness - United States, February 2013. MMWR Morb Mortal Wkly Rep2013; 62:119 - 23; PMID: 23425960
  • McMenaminJ, AndrewsN, RobertsonC, FlemingD, DurnallH, von WissmannB, EllisJ, LackenbyA, CottrellS, SmythB, et al. Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13. Euro Surveill2013; 18:18; PMID: 23399421
  • JanjuaNZ, SkowronskiDM, De SerresG, DickinsonJ, CrowcroftNS, TaylorM, WinterAL, HottesTS, FonsecaK, CharestH, et al. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada’s sentinel surveillance system: cross-protection against major and minor variants. J Infect Dis2012; 205:1858 - 68; http://dx.doi.org/10.1093/infdis/jis283; PMID: 22492921
  • Jimenez-JorgeS, PozoF, de MateoS, Delgado-SanzC, CasasI, Garcia-CenozM, CastillaJ, SanchoR, Etxebarriarteun-AranzabalL, QuinonesC, et al, Spanish Influenza Sentinel Surveillance System (SISS). Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study. Euro Surveill2014; 19:19; http://dx.doi.org/10.2807/1560-7917.ES2014.19.9.20727; PMID: 24626206
  • Plans-RubióP. The vaccination coverage required to establish herd immunity against influenza viruses. Prev Med2012; l55:72 - 7; http://dx.doi.org/10.1016/j.ypmed.2012.02.015; PMID: 22414740
  • World Health Organization (WHO). Prevention and control of influenza pandemics and annual epidemics.2003. Report No.: WHA56.19.
  • CarratF, FlahaultA. Influenza vaccine: the challenge of antigenic drift. Vaccine2007; 25:6852 - 62; http://dx.doi.org/10.1016/j.vaccine.2007.07.027; PMID: 17719149
  • BoniMF. Vaccination and antigenic drift in influenza. Vaccine2008; 26:Suppl 3C8 - 14; http://dx.doi.org/10.1016/j.vaccine.2008.04.011; PMID: 18773534
  • OsterholmMT, KelleyNS, SommerA, BelongiaEA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis2012; 12:36 - 44; http://dx.doi.org/10.1016/S1473-3099(11)70295-X; PMID: 22032844
  • CastillaJ, Martínez-BazI, NavascuésA, Fernandez-AlonsoM, ReinaG, GuevaraM, ChamorroJ, OrtegaMT, AlbénizE, PozoF, et al, Primary Health Care Sentinel Network, Network for Influenza Surveillance in Hospitals of Navarre. Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis. Euro Surveill2014; 19:19; http://dx.doi.org/10.2807/1560-7917.ES2014.19.6.20700; PMID: 24556347
  • SkowronskiDM, JanjuaNZ, De SerresG, SabaiducS, EshaghiA, DickinsonJA, FonsecaK, WinterAL, GubbayJB, KrajdenM, et al. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One2014; 9:e92153; http://dx.doi.org/10.1371/journal.pone.0092153; PMID: 24667168
  • SkowronskiDM, JanjuaNZ, De SerresG. Understanding suboptimal influenza vaccine effectiveness within the agent, host, and environment paradigm. Clin Infect Dis2013; 57:476 - 7; http://dx.doi.org/10.1093/cid/cit256; PMID: 23619812
  • TreanorJJ, TalbotHK, OhmitSE, ColemanLA, ThompsonMG, ChengPY, PetrieJG, LofthusG, MeeceJK, WilliamsJV, et al, US Flu-VE Network. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis2012; 55:951 - 9; http://dx.doi.org/10.1093/cid/cis574; PMID: 22843783
  • CastillaJ, Martínez-BazI, Martínez-ArtolaV, ReinaG, PozoF, García CenozM, GuevaraM, MoránJ, IrisarriF, ArriazuM, et al, Primary Health Care Sentinel Network, Network for Influenza Surveillance in Hospitals of Navarre. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill2013; 18:18; PMID: 23399423
  • LambertLC, FauciAS. Influenza vaccines for the future. N Engl J Med2010; 363:2036 - 44; http://dx.doi.org/10.1056/NEJMra1002842; PMID: 21083388
  • BaxterR, RayGT, FiremanBH. Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine2010; 28:7267 - 72; http://dx.doi.org/10.1016/j.vaccine.2010.08.088; PMID: 20832494
  • NicholKL. Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy. Vaccine2009; 27:6305 - 11; http://dx.doi.org/10.1016/j.vaccine.2009.07.006; PMID: 19840665
  • CastillaJ, GodoyP, DomínguezA, Martínez-BazI, AstrayJ, MartínV, Delgado-RodríguezM, BaricotM, SoldevilaN, MayoralJM, et al, CIBERESP Cases and Controls in Influenza Working Group Spain. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza. Clin Infect Dis2013; 57:167 - 75; http://dx.doi.org/10.1093/cid/cit194; PMID: 23532475
  • RidenhourBJ, CampitelliMA, KwongJC, RosellaLC, ArmstrongBG, MangtaniP, CalzavaraAJ, ShayDK. Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥ 65 years: estimates with generalized linear models accounting for healthy vaccinee effects. PLoS One2013; 8:e76318; http://dx.doi.org/10.1371/journal.pone.0076318; PMID: 24146855
  • ValencianoM, KisslingE, I-MOVE Case-Control Study Team. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13. Euro Surveill2013; 18:3; PMID: 23449183
  • KisslingE, ValencianoM, LarrauriA, OrosziB, CohenJM, NunesB, PitigoiD, RizzoC, RebolledoJ, Paradowska-StankiewiczI, et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill2013; 18:18; PMID: 23399425
  • BelongiaEA, KiekeBA, DonahueJG, GreenleeRT, BalishA, FoustA, LindstromS, ShayDK, Marshfield Influenza Study Group. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis2009; 199:159 - 67; http://dx.doi.org/10.1086/595861; PMID: 19086915
  • Puig-BarberàJ, Díez-DomingoJ, VareaAB, ChavarriGS, RodrigoJA, HoyosSP, VidalDG. Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine2007; 25:7313 - 21; http://dx.doi.org/10.1016/j.vaccine.2007.08.039; PMID: 17889411
  • OrensteinEW, De SerresG, HaberMJ, ShayDK, BridgesCB, GargiulloP, OrensteinWA. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol2007; 36:623 - 31; http://dx.doi.org/10.1093/ije/dym021; PMID: 17403908
  • European Centers for Disease Control. Influenza case definition. [cited 2014 Jun 1]; Available from: URL: http://ecdc.europa.eu/en/activities/surveillance/eisn/surveillance/pages/influenza_case_definitions.aspx

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.